Novel NDUFA12 variants are associated with isolated complex I defect and variable clinical manifestation.


Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
06 2021
Historique:
revised: 27 01 2021
received: 08 09 2020
accepted: 06 03 2021
pubmed: 15 3 2021
medline: 29 1 2022
entrez: 14 3 2021
Statut: ppublish

Résumé

Isolated biochemical deficiency of mitochondrial complex I is the most frequent signature among mitochondrial diseases and is associated with a wide variety of clinical symptoms. Leigh syndrome represents the most frequent neuroradiological finding in patients with complex I defect and more than 80 monogenic causes have been involved in the disease. In this report, we describe seven patients from four unrelated families harboring novel NDUFA12 variants, with six of them presenting with Leigh syndrome. Molecular genetic characterization was performed using next-generation sequencing combined with the Sanger method. Biochemical and protein studies were achieved by enzymatic activities, blue native gel electrophoresis, and western blot analysis. All patients displayed novel homozygous mutations in the NDUFA12 gene, leading to the virtual absence of the corresponding protein. Surprisingly, despite the fact that in none of the analyzed patients, NDUFA12 protein was detected, they present a different onset and clinical course of the disease. Our report expands the array of genetic alterations in NDUFA12 and underlines phenotype variability associated with NDUFA12 defect.

Identifiants

pubmed: 33715266
doi: 10.1002/humu.24195
doi:

Substances chimiques

NDUFA12 protein, human 0
NADPH Dehydrogenase EC 1.6.99.1
Electron Transport Complex I EC 7.1.1.2

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

699-710

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Baide-Mairena, H., Gaudó, P., Marti-Sánchez, L., Emperador, S., Sánchez-Montanez, A., Alonso-Luengo, O., Correa, M., Grau, A. M., Ortigoza-Escobar, J. D., Artuch, R., Vázquez, E., Del Toro, M., Garrido-Pérez, N., Ruiz-Pesini, E., Montoya, J., Bayona-Bafaluy, M. P., & Pérez-Dueñas, B. (2019). Mutations in the mitochondrial complex I assembly factor NDUFAF6 cause isolated bilateral striatal necrosis and progressive dystonia in childhood. Molecular Genetics and Metabolism, 126, 250-258. https://doi.org/10.1016/j.ymgme.2019.01.001
Bannwarth, S., Procaccio, V., Lebre, A. S., Jardel, C., Chaussenot, A., Hoarau, C., Maoulida, H., Charrier, N., Gai, X., Xie, H. M., Ferre, M., Fragaki, K., Hardy, G., Mousson de Camaret, B., Marlin, S., Dhaenens, C. M., Slama, A., Rocher, C., Paul Bonnefont, J., … Paquis-Flucklinger, V. (2013). Prevalence of rare mitochondrial DNA mutations in mitochondrial disorders. Journal of Medical Genetics, 50, 704-714. https://doi.org/10.1136/jmedgenet-2013-101604
Bauer, P., Kandaswamy, K. K., Weiss, M. E. R., Paknia, O., Werber, M., Bertoli-Avella, A. M., Yüksel, Z., Bochinska, M., Oprea, G. E., Kishore, S., Weckesser, V., Karges, E., & Rolfs, A. (2019). Development of an evidence-based algorithm that optimizes sensitivity and specificity in ES-based diagnostics of a clinically heterogeneous patient population. Genetics in Medicine, 21, 53-61. https://doi.org/10.1038/s41436-018-0016-6
Bridges, H. R., Fedor, J. G., Blaza, J. N., Di Luca, A., Jussupow, A., Jarman, O. D., Wright, J. J., Agip, A. N. A., Gamiz-Hernandez, A. P., Roessler, M. M., Kaila, V. R. I., & Hirst, J. (2020). Structure of inhibitor-bound mammalian complex I. Nature Communication, 11, 5261. https://doi.org/10.1038/s41467-020-18950-3
Bonfante, E., Koenig, M. K., Adejumo, R. B., Perinjelil, V., & Riascos, R. F. (2016). The neuroimaging of Leigh syndrome: case series and review of the literature. Pediatric Radiology, 46, 443-451. https://doi.org/10.1007/s00247-015-3523-5
Bugiani, M., Invernizzi, F., Alberio, S., Briem, E., Lamantea, E., Carrara, F., Moroni, I., Farina, L., Spada, M., Donati, M. A., Uziel, G., & Zeviani, M. (2004). Clinical and molecular findings in children with complex I deficiency. Biochimica et Biophysica Acta, 1659, 136-147. https://doi.org/10.1016/j.bbabio.2004.09.006
Fassone, E., & Rahman, S. (2012). Complex I deficiency: clinical features, biochemistry and molecular genetics. Journal of Medical Genetics, 49, 578-590. https://doi.org/10.1136/jmedgenet-2012-101159
Gardeitchik, T., Mohamed, M., Ruzzenente, B., Karall, D., Guerrero-Castillo, S., Dalloyaux, D., van den Brand, M., van Kraaij, S., van Asbeck, E., Assouline, Z., Rio, M., de Lonlay, P., Scholl-Buergi, S., Wolthuis, D. F. G. J., Hoischen, A., Rodenburg, R. J., Sperl, W., Urban, Z., Brandt, U., … Morava, E. (2018). Bi-allelic mutations in the mitochondrial ribosomal protein MRPS2 cause sensorineural hearing loss, hypoglycemia, and multiple OXPHOS complex deficiencies. American Journal of Human Genetics, 102, 685-695. https://doi.org/10.1016/j.ajhg.2018.02.012
Heidary, G., Calderwood, L., Cox, G. F., Robson, C. D., Teot, L. A., Mullon, J., & Anselm, I. J. (2014). Optic atrophy and a Leigh-like syndrome due to mutations in the c12orf65 gene: report of a novel mutation and review of the literature. Neuro-Ophthalmology, 34, 39-43. https://doi.org/10.1097/WNO.0000000000000076
Invernizzi, F., D'Amato, I., Jensen, P. B., Ravaglia, S., Zeviani, M., & Tiranti, V. (2012). Microscale oxygraphy reveals OXPHOS impairment in MRC mutant cells. Mitochondrion, 12, 328-335. https://doi.org/10.1016/j.mito.2012.01.001
Kanungo, S., Morton, J., Neelakantan, M., Ching, K., Saeedian, J., & Goldstein, A. (2018). Mitochondrial disorders. Annals of Translational Medicine, 6, 475. https://doi.org/10.21037/atm.2018.12.13
Lake, N. J., Compton, A. G., Rahman, S., & Thorburn, D. R. (2016). Leigh syndrome: One disorder, more than 75 monogenic causes. Annals of Neurology, 79, 190-203. https://doi.org/10.1002/ana.24551
La Piana, R., Weraarpachai, W., Ospina, L. H., Tetreault, M., Majewski, J., Bruce Pike, G., Decarie, J. C., Tampieri, D., Brais, B., & Shoubridge, E. A. (2017). Identification and functional characterization of a novel MTFMT mutation associated with selective vulnerability of the visual pathway and a mild neurological phenotype. Neurogenetics, 18, 97-103. https://doi.org/10.1007/s10048-016-0506-0
Leigh, P. N., Al-Sarraj, S., & DiMauro, S. (2015). Impact commentaries. Subacute necrotizing encephalomyelopathy (Leigh's disease; Leigh syndrome). Journal of Neurology, Neurosurgery & Psychiatry, 86, 363-365. https://doi.org/10.1136/jnnp-2012-304601
Legati, A., Reyes, A., Nasca, A., Invernizzi, F., Lamantea, E., Tiranti, V., Garavaglia, B., Lamperti, C., Ardissone, A., Moroni, I., Robinson, A., Ghezzi, D., & Zeviani, M. (2016). New genes and pathomechanisms in mitochondrial disorders unraveled by NGS technologies. Biochimica et Biophysica Acta, 1857, 1326-1335. https://doi.org/10.1016/j.bbabio.2016.02.022
Mayr, J. A., Haack, T. B., Freisinger, P., Karall, D., Makowski, C., Koch, J., Feichtinger, R. G., Zimmermann, F. A., Rolinski, B., Ahting, U., Meitinger, T., Prokisch, H., & Sperl, W. (2015). Spectrum of combined respiratory chain defects. Journal of Inherited Metabolic Disease, 38, 629-640. https://doi.org/10.1007/s10545-015-9831-y
Melchionda, L., Haack, T. B., Hardy, S., Abbink, T. E. M., Fernandez-Vizarra, E., Lamantea, E., Marchet, S., Morandi, L., Moggio, M., Carrozzo, R., Torraco, A., Diodato, D., Strom, T. M., Meitinger, T., Tekturk, P., Yapici, Z., Al-Murshedi, F., Stevens, R., Rodenburg, R. J., … Zeviani, M. (2014). Mutations in APOPT1, encoding a mitochondrial protein, cause cavitating leukoencephalopathy with cytochrome c oxidase deficiency. American Journal of Human Genetics, 95, 315-325. https://doi.org/10.1016/j.ajhg.2014.08.003
Ostergaard, E., Rodenburg, R. J., van den Brand, M., Thomsen, L. L., Duno, M., Batbayli, M., Wibrand, F., & Nijtmans, L. (2011). Respiratory chain complex I deficiency due to NDUFA12 mutations as a new cause of Leigh syndrome. Journal of Medical Genetics, 48, 737-740. https://doi.org/10.1136/jmg.2011.088856
Parey, K., Haapanen, O., Sharma, V., Köfeler, H., Züllig, T., Prinz, S., Siegmund, K., Wittig, I., Mills, D. J., Vonck, J., Kühlbrandt, W., & Zickermann, V. (2019). High-resolution cryo-EM structures of respiratory complex I: Mechanism, assembly, and disease. Science Advances, 5, eaax9484. https://doi.org/10.1126/sciadv.aax9484
Piekutowska-Abramczuk, D., Assouline, Z., Mataković, L., Feichtinger, R. G., Koňařiková, E., Jurkiewicz, E., Stawiński, P., Gusic, M., Koller, A., Pollak, A., Gasperowicz, P., Trubicka, J., Ciara, E., Iwanicka-Pronicka, K., Rokicki, D., Hanein, S., Wortmann, S. B., Sperl, W., Rötig, A., … Mayr, J. A. (2018). NDUFB8 mutations cause mitochondrial complex I deficiency in individuals with Leigh-like encephalomyopathy. American Journal of Human Genetics, 102, 460-467. https://doi.org/10.1016/j.ajhg.2018.01.008
Pronicka, E., Piekutowska-Abramczuk, D., Ciara, E., Trubicka, J., Rokicki, D., Karkucińska-Więckowska, A., Pajdowska, M., Jurkiewicz, E., Halat, P., Kosińska, J., Pollak, A., Rydzanicz, M., Stawinski, P., Pronicki, M., Krajewska-Walasek, M., & Płoski, R. (2016). New perspective in diagnostics of mitochondrial disorders: Two years' experience with whole-exome sequencing at a national paediatric centre. Journal of Translational Medicine, 14, 174. https://doi.org/10.1186/s12967-016-0930-9
Rahman, S., & Thorburn, D. (2015). In M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. H. Bean, G. Mirzaa, & A. Amemiya (Eds.), GeneReviews® [Internet]. Nuclear gene-encoded leigh syndrome spectrum overview. (pp. 1993-2021). University of Washington.
Rak, M., & Rustin, P. (2014). Supernumerary subunits NDUFA3, NDUFA5 and NDUFA12 are required for the formation of the extramembrane arm of human mitochondrial complex I. FEBS Letters, 588, 1832-1838. https://doi.org/10.1016/j.febslet.2014.03.046
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Lyon, E., Spector, E., Voelkerding, K., & Rehm, H. L., ACMG Laboratory Quality Assurance Committee. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17, 405-424. https://doi.org/10.1038/gim.2015.30
Saada, A., Edvardson, S., Shaag, A., Chung, W. K., Segel, R., Miller, C., Jalas, C., & Elpeleg, O. (2012). Combined OXPHOS complex I and IV defect, due to mutated complex I assembly factor C20ORF7. Journal of Inherited Metabolic Disease, 35, 125-131. https://doi.org/10.1007/s10545-011-9348-y
Saoura, M., Powell, C. A., Kopajtich, R., Alahmad, A., AL-Balool, H. H., Albash, B., Alfadhel, M., Alston, C. L., Bertini, E., Bonnen, P. E., Bratkovic, D., Carrozzo, R., Donati, M. A., Di Nottia, M., Ghezzi, D., Goldstein, A., Haan, E., Horvath, R., Hughes, J., … Minczuk, M. (2019). Mutations in ELAC2 associated with hypertrophic cardiomyopathy impair mitochondrial tRNA 3′-end processing. Human Mutation, 40, 1731-1748. https://doi.org/10.1002/humu.23777
Simon, M. T., Eftekharian, S. S., Stover, A. E., Osborne, A. F., Braffman, B. H., Chang, R. C., Wang, R. Y., Steenari, M. R., Tang, S., Hwu, P. W. L., Taft, R. J., Benke, P. J., & Abdenur, J. E. (2019). Novel mutations in the mitochondrial complex I assembly gene NDUFAF5 reveal heterogeneous phenotypes. Molecular Genetics and Metabolism, 126, 53-63. https://doi.org/10.1016/j.ymgme.2018.11.001
Sofou, K., de Coo, I. F. M., Ostergaard, E., Isohanni, P., Naess, K., De Meirleir, L., Tzoulis, C., Uusimaa, J., Lönnqvist, T., Bindoff, L. A., Tulinius, M., & Darin, N. (2018). Phenotype-genotype correlations in Leigh syndrome: new insights from a multicentre study of 96 patients. Medical Genetics, 55, 21-27. https://doi.org/10.1136/jmedgenet-2017-104891
Torraco, A., Bianchi, M., Verrigni, D., Gelmetti, V., Riley, L., Niceta, M., Martinelli, D., Montanari, A., Guo, Y., Rizza, T., Diodato, D., Di Nottia, M., Lucarelli, B., Sorrentino, F., Piemonte, F., Francisci, S., Tartaglia, M., Valente, E. M., Dionisi-Vici, C., … Carrozzo, R. (2017). A novel mutation in NDUFB11 unveils a new clinical phenotype associated with lactic acidosis and sideroblastic anemia. Clinical Genetics, 91, 441-447. https://doi.org/10.1111/cge.12790
Zerbetto, E., Vergani, L., & Dabbeni-Sala, F. (1997). Quantification of muscle mitochondrial oxidative phosphorylation enzymes via histochemical staining of blue native polyacrylamide gels. Electrophoresis, 18, 2059-2064. https://doi.org/10.1002/elps.1150181131

Auteurs

Alessandra Torraco (A)

Department of Neurosciences, Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Alessia Nasca (A)

Diagnostic and Technology Department, Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Daniela Verrigni (D)

Department of Neurosciences, Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Alessandra Pennisi (A)

UNITE INSERM U1163 Imagine Institute, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Maha S Zaki (MS)

Human Genetics and Genome Research Division, Clinical Genetics Department, National Research Centre, Cairo, Egypt.

Giorgia Olivieri (G)

Department of Pediatric Subspecialties, Division of Metabolism, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Zahra Assouline (Z)

UNITE INSERM U1163 Imagine Institute, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Diego Martinelli (D)

Department of Pediatric Subspecialties, Division of Metabolism, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Reza Maroofian (R)

Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, London, UK.

Teresa Rizza (T)

Department of Neurosciences, Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Michela Di Nottia (M)

Department of Neurosciences, Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Federica Invernizzi (F)

Diagnostic and Technology Department, Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Eleonora Lamantea (E)

Diagnostic and Technology Department, Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Daniela Longo (D)

Department of Diagnostic Imaging, Unit of Neuroradiology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Henry Houlden (H)

Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, London, UK.

Holger Prokisch (H)

Institute of Neurogenomics, Helmholtz Zentrum München, Neuherberg, Germany.
Institute of Human Genetics, Technische Universität München, Munich, Germany.

Agnès Rötig (A)

UNITE INSERM U1163 Imagine Institute, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Carlo Dionisi-Vici (C)

Department of Pediatric Subspecialties, Division of Metabolism, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Enrico Bertini (E)

Department of Neurosciences, Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Daniele Ghezzi (D)

Diagnostic and Technology Department, Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Rosalba Carrozzo (R)

Department of Neurosciences, Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Daria Diodato (D)

Department of Neurosciences, Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH